Dr. Rosenberg is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
12401 E. 17th Avenue
Mail Stop B132
Aurora, CO 80045
Summary
- I am an Associate Professor of Medicine at the University of Colorado Health Sciences Center, with a faculty clinical cardiac electrophysiologist in the Division of Cardiology for the University of Colorado Hospital. I am the medical director of the ECG Laboratory for the University of Colorado Hospital. I am also the director of the Individualized Data Analysis Organization, where we investigate quantitative methods for analysis and application of individual-level device and monitor data. My research is funded by the NIH to focus on translational approaches to the study of cardiac arrhythmias through the use of advances in human genetics and advanced quantitative methods.
Education & Training
- Beth Israel Deaconess Medical CenterFellowship, Clinical Cardiac Electrophysiology, 2012 - 2013
- Beth Israel Deaconess Medical CenterFellowship, Cardiovascular Disease, 2009 - 2012
- Beth Israel Deaconess Medical CenterResidency, Internal Medicine, 2004 - 2007
- Albert Einstein College of MedicineClass of 2004
Certifications & Licensure
- CO State Medical License 2016 - 2025
- MA State Medical License 2006 - 2017
- American Board of Internal Medicine Cardiovascular Disease
- American Board of Internal Medicine Clinical Cardiac Electrophysiology
- American Board of Internal MedicineClinical Cardiac Electrophysiology
Clinical Trials
- Genetics of QT Response to Moxifloxacin Start of enrollment: 2013 Oct 01
- A Registry to Determine the Clinical and Genetic Risk Factors for Torsade De Pointes Start of enrollment: 2013 Oct 01
Publications & Presentations
PubMed
- Development and validation of the Atri-Risk Conduction Index risk score to predict risk of atrial fibrillation after typical atrial flutter ablation.Alex Grubb, Ryan Aleong, Michael A Rosenberg, Shu Chang, Kishan Padalia
Heart Rhythm. 2024-09-01 - Evaluating the prescribing and monitoring of medications associated with QTc-prolongation in the ambulatory care setting.Rachel N Lowe, Garth Wright, Lucas Olivas, Candance Teel, Krithika Suresh
Journal of Evaluation in Clinical Practice. 2024-04-01 - 1 citationsRight versus left-sided implantation of left bundle branch area pacemaker insertion.Carmel Ashur, Francis Zirille, Ryan G Aleong, Paul D Varosy, J Jason West
Journal of Interventional Cardiac Electrophysiology. 2024-03-01
Authored Content
- Individualized Risk Stratification of Sudden Cardiac Death: A New Take on Components of the Decision-Making ProcessOctober 2018
- Components of an Individualized Medicine ApproachAugust 2018
- The Need for Individualized Approaches to MedicineJune 2018
Press Mentions
- Do Tall Guys Die Younger?September 16th, 2015
Grant Support
- DEVELOPMENT OF END-TO-END CLINICAL DECISION SUPPORT TOOLS TO PREVENT CARDIOTOXIC DRUG RESPONSENIH/NHLBI2020–2025
- Influence of genetic variation on QT prolongation over the lifecourse and as a cardiotoxic drug responseNIH-NHLBI2018–2022
- Genetics of Cardiotoxic Drug ResponseNIH-NHLBI2015–2021
- Loan Repayment ProgramNational Institute of Health2014–2020
External Links
- Individualized Data Analysis Organizationhttp://analyzemydata.org
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: